Masahiro Fujii

Gene Regulation by Tyrosine Kinases: <i>src</i> Protein Activates Various Promoters, Including c- <i>fos</i>

Masahiro Fujii, David Shalloway, Inder M. Verma · Molecular and Cellular Biology · 1989 · 65 citations

Life Sciences, Cell Biology, Molecular Biology +17

A Novel, Selective, and Orally Available Antagonist for CC Chemokine Receptor 3

Tatsuaki Morokata, Keiko Suzuki, Y. Masunaga et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 55 citations

Medicine, Immunology, Pharmacology +17

Expression of FAP-1 (Fas-Associated Phosphatase) and Resistance to Fas-Mediated Apoptosis in T Cell Lines Derived from Human T Cell Leukemia Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis Patients

Masaaki Arai, Mari Kannagi, Masao Matsuoka et al. · AIDS Research and Human Retroviruses · 1998 · 47 citations

Life Sciences, Immunology, Pathology +17

Efficacy of intraoperative mapping to optimize the surgical ablation of atrial fibrillation in cardiac surgery

Shigeo Yamauchi, Hidetugu Ogasawara, Yoshiaki Saji et al. · The Annals of Thoracic Surgery · 2002 · 34 citations · Full text

Medicine, Cardiology, Surgery +17

Spiro-Substituted Piperidines as Neurokinin Receptor Antagonists. I. Design and Synthesis of (.+-.)-N-(2-(3,4-Dichlorophenyl)-4-(spiro(isobenzofuran-1(3H),4'-piperidin)-1'-yl)butyl)-N-methylbenzamide, YM-35375, as a New Lead Compound for Novel Neurokinin Receptor Antagonists.

Hirokazu Kubota, Masahiro Fujii, Ken‐ichi Ikeda et al. · Chemical and Pharmaceutical Bulletin · 1998 · 31 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15